EPISODE · Oct 10, 2025 · 12 MIN
Obesity medicines, aldosterone and CVD, inhalers, and antibiotic importation
from TT HealthWatch · host David Peregrino
Program notes:0:40 Aldosterone as a risk factor for heart disease1:40 Spectrum of renin-aldosterone levels2:40 As many as 25-30% may have3:11 All pharmacologic interventions for obesity tx4:14 All effective compared with placebo5:12 Meta-analysis 6:13 Very little data in overweight or massively obese6:35 Where do U.S. antibiotics come from?7:35 India leading country for finished product8:20 Environmental impact of inhalers9:20 Annual emissions increased by 24%10:23 Decreased by 43%11:23 Three forms of inhaler12:40 End
Embed this episode
What this episode covers
This week's topics include a look at obesity medicines in adults, aldosterone and CVD risk, environmental impact of inhalers, and where U.S. antibiotics are originating.
NOW PLAYING
Obesity medicines, aldosterone and CVD, inhalers, and antibiotic importation
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.